lobbying_activities: 2028816
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2028816 | ac7d7cea-fd84-4181-957b-ac5ac2fa692f | Q3 | WILLIAMS AND JENSEN, PLLC | 41454 | MT PHARMA AMERICA, INC. | 2017 | third_quarter | MED | Matters affecting access to and pricing of pharmaceuticals; matters affecting the Orphan Drug Act. | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2017-10-18T10:10:59.813000-04:00 |